Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(♦)

Author
Soheila Rezapour-Firouzi, Seyed Arefhosseini, Mehdi Farhoudi, Mehrangiz Ebrahimi-Mamaghani, Mohammad-Reza Rashidi, Mohammad-Ali Torbati, Behzad Baradaran
Keywords
Abstract

INTRODUCTION: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Because of limited efficacy and adverse side effects, identifying novel therapeutic and protective agents is important. The aim of this study is to examine the correlations between expanded disability status scale (EDSS) and cytokines after intervention with co-supplemented hemp seed and evening primrose oils and hot-natured diet in patients with relapsing-remitting multiple sclerosis (RRMS).

METHODS: We studied a group of 23 patients with clinically definite RRMS, with EDSS<6 who received co-supplemented hemp seed and evening primrose oils with advising hot-natured diet. Clinically EDSS and immunological factors (plasma cytokines of IL-4, IFN-γ and IL-17) were assessed at baseline and after 6 months.

RESULTS: Mean follow-up was 180±2.9 days (N=23, 7 Male and 16 Females aged 25.0±7.5 years with disease duration 6.26±3.9 years). After 6 months, significant improvements in extended disability status score were found in the patients in agreement with decrease cytokines of IFN-γ and IL-17 and increase cytokines of IL-4. Clinical and immunological parameters showed improvement in the patients after the intervention.

CONCLUSION: Our study shows that co-supplemented hemp seed and evening primrose oils with hot-natured diet can have beneficial effects in improving clinical symptoms in relapsing remitting MS patients and significant correlation was found between EDSS and immunological findings.

Year of Publication
2013
Journal
BioImpacts : BI
Volume
3
Issue
1
Number of Pages
43-7
Date Published
01/2013
ISSN Number
2228-5652
DOI
10.5681/bi.2013.001
Alternate Journal
Bioimpacts
PMCID
PMC3648912
PMID
23678469
Download citation
Reactivity
Human
Category
ELISA
Analyte
IFN-γ, IL-4, IL-17A